oa Editorial

Welcome to a new year and new volume of the CRR! As in past years, we promise to provide high quality, thought provoking articles of current interest to the general rheumatologist in the forthcoming issues. The purpose of this journal is to provide a forum for thought leaders to disseminate useful insights to general rheumatologists, and to publish worthy reviews from expert phsyicians. In pursuing this goal, we are proud to publish reviews of organ involvement in the antiphospholipid syndrome (APS) by Dr. Cervera and his colleagues. Dr. Cervera and his European colleagues have contributed greatly to the field of APS research through the publication of prospective data on morbidity and mortality associated with the APS [1]. Thus, there is no one better to guest edit a hot topic issue on APS than Dr. Cervera and indeed you will find great pleasure in reading these review articles and discovering valuable insights about APS from the luminaries in this field. Dr. Cervera and colleagues lay the foundation for understanding the diverse organ manifestations of this syndrome, which would be of interest to any rheumatologist, but also have significance to other subspecialists such as ophthalmologists, dermatologists, pulmonologists, neurologists, endocrinologists etc. In addition to the hot topic issue, we publish an excellent review of psoriatic arthritis treatments, a field where there are several new treatment options available. Lastly, we publish two thoughtful review articles from our orthopedic colleagues about ankle and foot involvment in RA and isolated cartilage lesions in knee. We welcome your comments about the articles and hope that these articles will lead to a healthy debate about some of the thoughts presented.